Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double-Blind, Placebo-Controlled, Active-Referenced, Parallel-Group Comparative Study in Patients With Benign Prostatic Hyperplasia

NCT02038868 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

NCT NCT02038868
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02038868 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double-Blind, Placebo-Controlled, Active-Referenced, Parallel-Group Comparative Study in Patients With Benign Prostatic Hyperplasia
Lead sponsor
Astellas Pharma Inc
Phase
Phase 2
Overall status
Completed
Start date
July 22, 2013
Completion date
April 4, 2014
Enrollment
320 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

benign prostate hyperplasia